827 episodes

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.

Research To Practice | Oncology Videos Research To Practice

    • Science
    • 4.6 • 69 Ratings

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.

    • video
    Non-Small Cell Lung Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress

    Non-Small Cell Lung Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress

    Featuring perspectives from Dr Edward Garon, Ms Kelly Goodwin, Ms Tara Plues and Dr Anne Tsao, including the following topics:
    Introduction (0:00) Key Lung Cancer Diagnostic Tools (7:40) Targeted Therapy for Localized Disease (18:05) Targeted Therapy for Metastatic Disease (33:01) Immunotherapy for Localized Disease (1:31:18) Immunotherapy for Metastatic Disease (1:53:36) NCPD information and select publications

    • 2 hr 2 min
    • video
    Breast Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress

    Breast Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress

    Featuring perspectives from Ms Jamie Carroll, Dr Sara Hurvitz, Ms Kelly Leonard and Dr Hope Rugo, including the following topics:
    Introduction (0:00) High-Risk Localized ER-Positive, HER2-Negative Breast Cancer (5:07) ER-Positive Metastatic Breast Cancer (28:06) Localized HER2-Positive Breast Cancer (49:15) Metastatic HER2-Positive Breast Cancer (1:07:06) Localized Triple-Negative Breast Cancer (TNBC); Role of Immunotherapy (1:30:08) Metastatic TNBC (1:49:41) CME information and select publications

    • 2 hr
    • video
    Prostate Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress

    Prostate Cancer | Proceedings from a NCPD Symposium Held During the 47th Annual ONS Congress

    Featuring perspectives from Ms Kathy Burns, Dr Robert Dreicer, Dr Sandy Srinivas and Mr Ronald Stein, including the following topics:
    Introduction (0:00) PSA-Only Recurrence (M0 Disease) (10:45) Metastatic Hormone-Sensitive Prostate Cancer (35:07) Metastatic Castration-Resistant Prostate Cancer (BRCA Wild Type) (48:48) Metastatic Castration-Resistant Prostate Cancer (BRCA Mutant) (1:10:42) CME information and select publications

    • 1 hr 30 min
    • video
    Non-Small Cell Lung Cancer | Meet The Professor: Non-Small Cell Lung Cancer with an Actionable Target Beyond EGFR — Part 1

    Non-Small Cell Lung Cancer | Meet The Professor: Non-Small Cell Lung Cancer with an Actionable Target Beyond EGFR — Part 1

    Featuring perspectives from Dr Ross Camidge, including the following topics:
    Introduction: First-line systemic treatment; brain metastases (0:00) Case: A woman in her early 60s with squamous NSCLC metastatic to tbe brain and an ALK rearrangement; PD-L1 TPS 70% — Spencer Henick Bachow, MD (20:30) Case: A man in his early 70s with localized NSCLC with an ALK rearrangement and significant comorbidities — Sunil Gandhi, MD (24:44) Case: A woman and heart transplant recipient in her mid 70s with metastatic NSCLC with a KRAS G12C mutation; PD-L1 TPS 20% — Mamta Choksi, MD (30:26) Case: A woman in her late 70s with metastatic NSCLC and a MET exon 14 skipping mutation — Jennifer L Dallas, MD (36:01) Case: A woman in her late 60s with metastatic NSCLC and a HER2 exon 19 mutation pathogenic variant; PD-L1 TPS 15% — Rajni Sinha, MD, MRCP (41:43) Case: A man in his early 30s with metastatic NSCLC and an NTRK fusion; PD-L1 TPS 10% — Daniel R Carrizosa, MD, MS (46:09) Treatment for Patients with ROS1 Fusions (48:34) RET Fusions in Lung Cancer (52:38) BRAF Mutations (54:20) NRG Fusions (55:31) CME information and select publications

    • 59 min
    • video
    Hepatobiliary and Pancreatic Cancers | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hepatobiliary and Pancreatic Cancers

    Hepatobiliary and Pancreatic Cancers | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Hepatobiliary and Pancreatic Cancers

    Featuring perspectives from Drs Tanios Bekaii-Saab and Philip Philip, including the following topics: 
    Introduction (0:00) Treatment for Hepatocellular Carcinoma (14:52) Management of Biliary Tract Cancers (36:08) Clinical Decision-Making for Patients with Pancreatic Cancer (47:28) CME information and select publications 

    • 1 hr
    • video
    Ovarian Cancer | Oncology Today with Dr Neil Love: Updates on Ovarian Cancer from SGO 2022

    Ovarian Cancer | Oncology Today with Dr Neil Love: Updates on Ovarian Cancer from SGO 2022

    Featuring an interview with Dr David O'Malley, including the following topics:
    Efficacy and safety data with mirvetuximab soravtansine for ovarian cancer (OC) from the SORAYA trial (0:00) Potential integration of mirvetuximab soravtansine into clinical practice; biologic rationale for and mechanism of action of upifitamab rilsodotin in therapy for OC (6:30) Rationale for using tumor treating fields in combination with paclitaxel for OC; efficacy data with tumor treating fields for thoracic mesothelioma and glioblastoma multiforme (12:45) Ongoing work on quantitative tests to identify patients most likely to benefit from PARP inhibitors; real-world treatment patterns in OC (21:27) Single-agent neoadjuvant niraparib; emerging data with niraparib/bevacizumab and potential integration into treatment algorithms (28:46) PARP inhibitors in patients with BRCA wild-type OC; design, similarities and differences from the PRIME and PRIMA trials of maintenance niraparib (36:02) Ongoing MONO-OLA1 trial of olaparib with and without bevacizumab as up-front treatment for OC; final overall survival and second progression-free survival data from the SOLO-3 trial (42:28) CME information and select publications

    • 47 min

Customer Reviews

4.6 out of 5
69 Ratings

69 Ratings

a h/o ,

Valued resource

Relentless in its focus on the general medical oncolgist. An important resource.

obete man ,

Excellent

Since my fellowship training Neil Love has made these presentations the best of the best in staying UpToDate with current and future practice

OKMedStudent ,

RTP is is consistently great

Research to Practice continues to put out well produced clinically relevant content from expert faculty that is applicable to daily oncology practice. It is an invaluable resource for me.

Top Podcasts In Science

Hidden Brain
Alie Ward
Jordan Harbinger
Wes Larson, Jeff Larson, Mike Smith | QCODE
Science Friday and WNYC Studios
Neil deGrasse Tyson

You Might Also Like

Research To Practice
Dr Neil Love
Dr Neil Love
Dr Neil Love
Dr Neil Love
Vinay Prasad, MD MPH

More by Research To Practice

Dr Neil Love
Dr Neil Love
Dr Neil Love
Dr Neil Love
Dr Neil Love
Dr Neil Love